4.6 Editorial Material

Human Endotoxin Administration as an Experimental Model in Drug Development

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 4, Pages 418-422

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2014.146

Keywords

-

Funding

  1. Intramural NIH HHS Funding Source: Medline
  2. NCATS NIH HHS [UL1TR001117] Funding Source: Medline

Ask authors/readers for more resources

Linking human physiology to inflammatory mechanisms discovered in vitro or in animal models is essential to determine their importance. Innate immunity underlies many of these inflammatory responses in health and disease. Bacterial endotoxin is the quintessential trigger of innate immune responses. When administered to humans, endotoxin has been an important means of demonstrating key inflammatory mechanisms in vivo. Furthermore, endotoxin challenges have provided opportunities to test the effects of novel inflammation-modifying agents in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available